Literature DB >> 28980202

An Update on ISoP Special Interest Groups (SIGs).

Deirdre McCarthy1, Priya Bahri2, Joanne Barnes3, Jean-Christophe Delumeau4, Brian Edwards5, Mira Harrison-Woolrych6.   

Abstract

Mesh：

Year:  2018        PMID： 28980202     DOI： 10.1007/s40264-017-0603-5

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  3 in total

1.  The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.

Authors:  Priya Bahri; Alexander N Dodoo; Brian D Edwards; I Ralph Edwards; Irene Fermont; Ulrich Hagemann; Kenneth Hartigan-Go; Bruce Hugman; Peter G Mol
Journal:  Drug Saf       Date:  2015-07       Impact factor: 5.606

2.  Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum.

Authors:  Jürgen Beckmann; Ulrich Hagemann; Priya Bahri; Andrew Bate; Ian W Boyd; Gerald J Dal Pan; Brian D Edwards; I Ralph Edwards; Kenneth Hartigan-Go; Marie Lindquist; John McEwen; Yola Moride; Sten Olsson; Shanthi N Pal; Rachida Soulaymani-Bencheikh; Marco Tuccori; Claudia P Vaca; Ian C K Wong
Journal:  Drug Saf       Date:  2014-10       Impact factor: 5.606

3.  Focusing on risk communication about medicines: why now?

Authors:  Priya Bahri; Mira Harrison-Woolrych
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606
  3 in total
  2 in total

1.  The role and strategy of ISoP in global pharmacovigilance.

Authors:  Sten Olsson; Mira Harrison-Woolrych
Journal:  Int J Clin Pharm       Date:  2018-08-02

2.  Medication Errors Special Interest Group of the International Society of Pharmacovigilance and the Trends in International Collaboration for Patient Safety.

Authors:  Mohamed A Elhawary; Hadir Rostom; Brian Edwards; Angela Caro
Journal:  Drug Saf       Date:  2022-01-17       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.